4.7 Article

The balance between severe cardiovascular and gastrointestinal events among users of selective and non-selective non-steroidal anti-inflammatory drugs

期刊

ANNALS OF THE RHEUMATIC DISEASES
卷 68, 期 5, 页码 668-673

出版社

BMJ PUBLISHING GROUP
DOI: 10.1136/ard.2007.087254

关键词

-

资金

  1. Pfizer BV
  2. Capelle a/d Ijssel
  3. The Netherlands

向作者/读者索取更多资源

Objective: To simultaneously assess cardiovascular ( CV) and gastrointestinal (GI) risk with traditional non-steroidal anti-inflammatory drugs (tNSAIDs) and cyclo-oxygenase 2 (COX-2) inhibitors. Methods: Using the PHARMO Record Linkage System, including drug-dispensing and hospitalisation data of >2 million residents of The Netherlands, subjects with first hospitalisation for acute myocardial infarction ( AMI), CV and GI events were identified. Use of COX-2 inhibitors and traditional non-selective NSAIDs was classified into remote, recent and current. Cases were matched to controls in a 1: 4 ratio on age and event date. Multivariate analyses adjusted for gender, history of hospitalisations and medications. Results: Compared to remote use, AMI risk was increased among current users of COX-2 inhibitors combined ( adjusted odds ratio ( OR) 1.73, 95% CI 1.37 to 2.19) and tNSAIDs combined ( OR 1.41, 95% CI 1.23 to 1.61). AMI risk with celecoxib ( OR 2.53, 95% CI 1.53 to 4.18), rofecoxib ( OR 1.60, 95% CI 1.22 to 2.10), ibuprofen ( OR 1.56, 95% CI 1.19 to 2.05) and diclofenac ( OR 1.51, 95% CI 1.22 to 1.87) was significantly increased. CV risk with current use of individual COX-2 inhibitors and tNSAIDs was significantly increased ( OR from 1.17 to 1.64), as was GI risk with current use of rofecoxib ( OR 1.99, 95% CI 1.51 to 2.63), naproxen ( OR 4.44, 95% CI 3.36 to 5.86), ibuprofen ( OR 1.90, 95% CI 1.40 to 2.58), diclofenac ( OR 4.77, 95% CI 3.94 to 5.76), other tNSAIDs ( OR 2.59, 95% CI 2.08 to 3.21), but not celecoxib ( OR 1.36, 95% CI 0.70 to 2.66). Compared to current use of celecoxib and AMI risk was significantly decreased with current use of naproxen ( OR 0.48, 95% CI 0.26 to 0.87) only. GI risk was increased with current naproxen ( OR 3.26, 95% CI 1.59 to 6.70) and diclofenac ( OR 3.50, 95% CI 1.76 to 6.98). Conclusions: AMI and CV risk increased similarly with individual COX-2 inhibitors and tNSAIDs, whereas GI risk was found to be greater with naproxen and diclofenac. Residual confounding and channelling'' cannot be excluded.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Oncology

Statin use is associated with a reduced incidence of colorectal cancer expressing SMAD4

Sarah Ouahoud, Rutger J. Jacobs, Ludmilla L. Kodach, Philip W. Voorneveld, Lukas J. A. C. Hawinkels, Nikki L. Weil, Britt van Vliet, Ron M. Herings, Lennart R. A. Van der Burg, Tom van Wezel, Hans Morreau, Marije Slingerland, Esther Bastiaannet, Hein Putter, James C. H. Hardwick

Summary: This study found that long-term use of statins is associated with a reduced risk of developing colorectal cancer, particularly for SMAD4-positive colorectal cancer.

BRITISH JOURNAL OF CANCER (2022)

Article Pharmacology & Pharmacy

Infliximab use in the Netherlands: Uptake and characteristics of originator and biosimilars over time

Jetty A. Overbeek, Josephina G. Kuiper, Marina Bakker, B. J. F. ( Bart) Bemt, Ron M. C. Herings

Summary: The study aimed to provide an overview of the utilization of originator and biosimilar infliximab in the Netherlands. It found that while there was an increase in the use of biosimilars, the proportion of patients switching remained relatively low as nonmedical switch is not encouraged in the Netherlands.

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2022)

Article Behavioral Sciences

Twenty-year trends in the use of anti-seizure medication among pregnant women in the Netherlands

Eline Houben, Rachael J. Benson, Eric A. P. Steegers, Ron M. C. Herings

Summary: The study observed an increase in the use of known safest ASMs and ASMs with uncertain risk among pregnant women in the Netherlands over the past two decades, while the use of ASMs with higher risk of congenital malformations decreased. Only a small proportion of women switched to a safer alternative before or during pregnancy, with most either discontinuing treatment or switching within the same category.

EPILEPSY & BEHAVIOR (2022)

Article Gastroenterology & Hepatology

Use of topical mineral powder as monotherapy for treatment of active peptic ulcer bleeding

Joseph J. Y. Sung, Sulleman Moreea, Harinder Dhaliwal, Dana C. Moffatt, Krish Ragunath, Terry Ponich, Alan N. Barkun, Ernst J. Kuipers, Robert Bailey, Fergal Donnellan, David Wagner, Keith Sanborn, James Lau

Summary: The study evaluated the safety and effectiveness of Hemospray as a monotherapy for active peptic ulcer bleeding. Results showed that Hemospray was successfully administered in nearly all patients, with a high rate of hemostasis achieved. Recurrent bleeding was observed in a small percentage of patients, but no adverse events were attributed to the use of Hemospray.

GASTROINTESTINAL ENDOSCOPY (2022)

Article Multidisciplinary Sciences

Socioeconomic differences in participation and diagnostic yield within the Dutch national colorectal cancer screening programme with faecal immunochemical testing

Miriam P. van der Meulen, Esther Toes-Zoutendijk, Manon C. W. Spaander, Evelien Dekker, Johannes M. G. Bonfrer, Anneke J. van Vuuren, Ernst J. Kuipers, Folkert J. van Kemenade, M. F. van Velthuysen, Maarten G. J. Thomeer, Harriet van Veldhuizen, Harry J. de Koning, Iris Lansdorp-Vogelaar, Monique E. van Leerdam

Summary: The participation rate in FIT screening is lower for individuals with a lower socioeconomic status (SES), but they have a higher detection rate for advanced neoplasia. Screening has the potential to reduce health inequalities in CRC mortality.

PLOS ONE (2022)

Article Endocrinology & Metabolism

Levothyroxine use and the risk of colorectal cancer: a large population-based case-control study

Josephina G. Kuiper, Aline C. Fenneman, Anne H. van der Spek, Elena Rampanelli, Max Nieuwdorp, Myrthe P. P. Van Herk-Sukel, Valery E. P. P. Lemmens, Ernst J. Kuipers, Ron M. C. Herings, Eric Fliers

Summary: This study did not find a reduced risk of colorectal cancer in levothyroxine users. When stratified by tumour subsite, a borderline significant risk reduction of rectal cancer was found, indicating a need for further research.

ENDOCRINE CONNECTIONS (2022)

Article Gastroenterology & Hepatology

Autophagy mediates ER stress and inflammation in Helicobacter pylori-related gastric cancer

M. C. Mommersteeg, I Simovic, B. Yu, S. A. van Nieuwenburg, I. M. J. Bruno, M. Doukas, E. J. Kuipers, M. C. W. Spaander, M. P. Peppelenbosch, N. Castano-Rodriguez, G. M. Fuhler

Summary: The SNP in the ATG16L1 gene is associated with increased intestinal endoplasmic reticulum stress and progression of gastric cancer induced by H. pylori. Individuals with the G-allele are more prone to developing gastric cancer.

GUT MICROBES (2022)

Article Medicine, General & Internal

Treatment and low-density lipoprotein cholesterol levels in patients with hypercholesterolaemia or mixed dyslipidaemia at high or very high cardiovascular risk: a population-based cross-sectional study in the Netherlands

Edith M. Heintjes, Anastassia Anastassopoulou, Josephina Kuiper, Aikaterini Bilitou, Fernie J. A. Penning-van Beest, Ron M. C. Herings, Maarten J. Postma, J. Wouter Jukema

Summary: This study aimed to investigate the treatment patterns, LDL-C levels and healthcare resource utilization of patients with hypercholesterolaemia or mixed dyslipidaemia at high or very high cardiovascular risk in the Netherlands in 2018. The findings revealed suboptimal treatment with the majority of patients receiving statin monotherapy and only a small percentage receiving combination therapy. Alternative treatment strategies are required to further lower cardiovascular risk.

CURRENT MEDICAL RESEARCH AND OPINION (2023)

Article Primary Health Care

GPs' awareness of pregnancy: trends and association with hazardous medication use

Eline Houben, Karin M. A. Swart, Eric AP Steegers, Petra J. M. Elders, Ron MC Herings

Summary: This study examined GPs' awareness of pregnancy and its association with prescribing medication with potential safety risks to women. Results indicated that although GPs' awareness of pregnancy improved over time, inadequate use of available information systems for appropriate drug surveillance still exists.

BRITISH JOURNAL OF GENERAL PRACTICE (2023)

Article Public, Environmental & Occupational Health

Women on diuretics have a higher risk of hospital admission because of hyponatremia than men

Linda C. C. Hendriksen, Paul D. D. van Der Linden, Ron M. C. Herings, Bruno H. H. Stricker, Loes E. E. Visser

Summary: Recent studies indicate that women using diuretics have a higher risk of hospital admission due to diuretic-induced hyponatremia compared to men. This study aimed to determine whether these sex differences persist after adjusting for confounding variables.

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2023)

Article Public, Environmental & Occupational Health

Completeness and Representativeness of the PHARMO General Practitioner (GP) Data: A Comparison with National Statistics

Jetty A. Overbeek, Karin M. A. Swart, Eline Houben, Fernie J. A. Penning-van Beest, Ron M. C. Herings

Summary: This study aimed to assess the completeness and representativeness of the PHARMO GP data for the Dutch population. The findings showed that the PHARMO GP data were representative of the Dutch population in terms of demographic characteristics and diagnoses, but differences were observed in non-urbanized areas and medication use. Therefore, caution should be exercised when using this data for research purposes.

CLINICAL EPIDEMIOLOGY (2023)

Review Immunology

Effectiveness of COVID-19 Vaccines in Adults with Diabetes Mellitus: A Systematic Review

Jesse M. van den Berg, Sharon Remmelzwaal, Marieke T. Blom, Beryl A. C. E. Hoek, Karin M. A. Swart, Jetty A. Overbeek, George L. Burchell, Ron M. C. Herings, Petra J. M. Elders

Summary: Persons with diabetes have a higher risk of severe illness or death from COVID-19. The effectiveness of COVID-19 vaccines may be lower in individuals with diabetes. More research is needed to compare vaccine effectiveness between those with and without diabetes.

VACCINES (2023)

Article Pharmacology & Pharmacy

Time Trends in Patient Characteristics of New Rivaroxaban Users with Atrial Fibrillation in Germany and the Netherlands

Annemarie Voss, Elisabeth Smits, Karin M. A. Swart, Yanina Balabanova, Gunnar Brobert, Kiliana Suzart-Woischnik, Ron M. C. Herings, Tania Schink, Ulrike Haug

Summary: Since its market approval in 2011, the use of rivaroxaban, a direct oral anticoagulant, has significantly increased in Europe. The baseline characteristics of new rivaroxaban users with non-valvular atrial fibrillation in Germany and the Netherlands have changed over time, with an increasing proportion of patients in Germany not using oral anticoagulants prior to starting rivaroxaban and an increasing proportion of patients in the Netherlands having heart failure at baseline.

DRUGS-REAL WORLD OUTCOMES (2023)

Article Primary Health Care

Identification of frailty in primary care: accuracy of electronically derived measures

Karin M. A. Swart, Amber A. W. A. van der Heijden, Marieke T. Blom, Jetty A. Overbeek, Giel Nijpels, Hein P. J. van Hout, Petra J. M. Elders, Ron M. C. Herings

Summary: This study aimed to estimate the ability of using electronic medical record data to identify frailty in older patients. The Charlson Comorbidity Index (CCI) was found to be the only measure with acceptable performance, while the other measures showed poorer performance in older age groups.

BRITISH JOURNAL OF GENERAL PRACTICE (2023)

Article Pharmacology & Pharmacy

Safety and effectiveness of rivaroxaban for prevention of stroke in patients with nonvalvular atrial fibrillation: analysis of routine clinical data from four countries

Luis Alberto Garcia Rodriguez, Ana Ruigomez, Tania Schink, Annemarie Voss, Elisabeth Smits, Karin M. A. Swart, Yanina Balabanova, Kiliana Suzart-Woischnik, Gunnar Brobert, Ron M. C. Herings

Summary: This study evaluated the safety and effectiveness of rivaroxaban versus vitamin K antagonists in stroke prevention for patients with nonvalvular atrial fibrillation in Europe. The results showed that the incidence of intracranial bleeding was generally lower with rivaroxaban, while gastrointestinal and urogenital bleeding were higher.

EXPERT OPINION ON DRUG SAFETY (2023)

暂无数据